Variable |
Better GLS |
Worse GLS |
P
Value |
|
(n = 264) |
(n = 261) |
|
Age (y) |
58.7±8.3 [57.3] |
57.4±8.5 [56.0] |
0.07 |
Male gender |
167 (63.3%) |
210 (80.5%) |
<0.0001 |
Height (cm) |
169.8±10.0 [170.0] |
171.5±8.2 [172.0] |
0.033 |
Weight (kg) |
80.0 ±15.0 [79.0] |
84.7±15.5 [83.0] |
0.001 |
BMI (kg/m²) |
27.7±4.5 [27.3] |
28.7±4.7 [28.3] |
0.01 |
Known CAD |
20 (7.6%) |
28 (10.7%) |
0.21 |
Previous PCI |
17 (6.4%) |
26 (10.0%) |
0.14 |
TIMI score*
|
1.64±1.20 [1.0] |
1.82±1.10
[2.0] |
0.06 |
Risk factors |
|
|
|
Hypertension |
118 (44.7%) |
127 (48.7%) |
0.36 |
Diabetes |
59 (22.3%) |
72 (27.6%) |
0.17 |
Hyperlipidemia |
147 (55.7.0%) |
149 (57.0%) |
0.75 |
FH of CAD |
94 (35.6%) |
89 (34.0%) |
0.72 |
Current smoker |
80 (30.3%) |
106 (40.6%) |
0.014 |
Medications at enrolment |
|
|
|
Aspirin |
110 (41.7%) |
108 (41.4%) |
0.97 |
Beta blockers |
47 (17.8%) |
49 (18.8%) |
0.77 |
Nitrates |
6 (2.3%) |
3 (1.1%) |
0.32 |
ACE-I |
47 (17.8%) |
59 (22.6%) |
0.17 |
ARB |
25 (9.3%) |
18 (6.9%) |
0.28 |
CCB |
35 (13.3%) |
28 (10.7%) |
0.37 |
Laboratory results |
|
|
|
Creatinine (mg%) |
0.85±0.18 [0.83] |
0.90±0.20 [0.89] |
0.004 |
Hb (g%) |
13.9±1.3 [14.0] |
14.3±1.4 [14.3] |
0.009 |
Troponin T (ng/L)† |
15.32±64.0 [7.0] |
34.8±142.8 [4.0] |
0.73 |